Dopamine D1 receptor and sigma receptors (D1R/SigmaR)

The Dopamine D1 receptor (DRD1) is a G protein-coupled receptor that primarily stimulates adenylyl cyclase, playing a critical role in the regulation of motor control, executive function, and reward-related behaviors (UniProt P21728). Sigma receptors, comprising the Sigma-1 (SIGMAR1) and Sigma-2 (TMEM97) subtypes, are distinct proteins; Sigma-1 functions as a molecular chaperone at the endoplasmic reticulum-mitochondrion interface, where it regulates calcium signaling and cellular stress responses (UniProt Q99720, Q5BJF2). These two systems are often studied together because Sigma-1 receptors can form physical and functional complexes with D1 receptors, thereby modulating dopaminergic signaling and receptor trafficking (Moreno et al., 2014, PubMed 24508554). In clinical contexts, this dual target system is relevant for neuropsychiatric disorders such as schizophrenia and Parkinson's disease, where imbalances in dopaminergic tone and cellular proteostasis occur (StatPearls, Biochemistry, Dopamine Receptors). Many classical antipsychotics, such as haloperidol and fluphenazine, interact with both dopamine and sigma receptors, contributing to their complex pharmacological profiles and side effect risks (PubChem CID 3503). Research into selective dual ligands aims to harness the neuroprotective properties of sigma modulation alongside the symptomatic benefits of D1 receptor regulation.

Other names

D1 receptor and sigma binding sitesDopamine receptor D1 and sigma-1/sigma-2 receptorsDRD1 and SIGMAR1/TMEM97D1R and sigma sites

Simultaneous modulation of Gs-coupled signaling via Dopamine D1 receptors and chaperone-mediated cellular stress responses via Sigma-1 receptors.